NEW YORK, May 24, 2017 /PRNewswire/ --
On Tuesday, the NASDAQ Composite ended the day at 6,138.71, up 0.08%; theDow Jones Industrial Average edged 0.21% higher, to finish at 20,937.91; and the S&P 500 closed at 2,398.42, marginally gaining 0.18%. Gains were broad based as five out of nine sectors finished the trading session in green. Stock-Callers.com has
San Diego, California headquartered Biocept Inc.'s stock finished Tuesday's session 2.63% lower at $1.48. A total volume of 1.09 million shares was traded, which was above their three months average volume of 999,840 shares. The Company's shares have surged 90.97% since the start of this year. The stock is trading 2.96% below its 200-day moving average. Additionally, shares of Biocept, which develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample, have a Relative Strength Index (RSI) of 37.40. BIOC complete research report is just a click away and free at:
Varian Medical Systems
On Tuesday, shares in Palo Alto, California headquartered Varian Medical Systems Inc. recorded a trading volume of 452,186 shares. The stock ended the session 0.31% higher at $95.95. The Company's shares have advanced 8.54% in the last one month, 14.86% in the previous three months, and 20.69% on an YTD basis. The stock is trading 4.80% above its 50-day moving average and 13.22% above its 200-day moving average. Moreover, shares of Varian Medical Systems, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have an RSI of 65.26.
On May 16th, 2017, research firm Goldman initiated a 'Neutral' rating on the Company's stock, with a target price of $92 per share. The complimentary report on VAR can be downloaded at:
Chicago, Illinois headquartered Hill-Rom Holdings Inc.'s shares closed the day 0.32% lower at $75.25. The stock recorded a trading volume of 366,139 shares. The Company's shares have gained 4.48% in the last month, 16.22% over the previous three months, and 34.04% on an YTD basis. The stock is trading 4.55% and 21.01% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Hill-Rom, which operates as a medical technology company worldwide, have an RSI of 61.10.
On May 01st, 2017, research firm Stifel reiterated its 'Buy' rating on the Company's stock with an increase of the target price from $70 a share to $84 a share. Sign up for your complimentary research report on HRC at:
Shares in Franklin, Tennessee headquartered Tivity Health Inc. finished 0.15% lower at $32.55. The stock recorded a trading volume of 333,184 shares. The Company's shares have advanced 12.24% in the last one month, 19.23% in the previous three months, and 43.08% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 8.19% and 25.87%, respectively. Furthermore, shares of Tivity Health, which together with its subsidiaries, provides network delivered solutions and population health management services to help people to enhance well-being and health, have an RSI of 57.95. Get free access to your research report on TVTY at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: firstname.lastname@example.org Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...
Rosacea is a chronic skin condition marked by facial redness and swelling especially around the ...
Immunotherapy is a type of treatment method that works by using certain components of a person's ...View All